2,490.00
+40.00
+(1.63%)
At close: January 17 at 2:12:33 PM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 19 | 16 | 26 | 25 |
| Avg. Estimate | 1.9B | 1.9B | 6.97B | 8.3B |
| Low Estimate | 1.86B | 1.8B | 6.93B | 8.05B |
| High Estimate | 2.05B | 2.13B | 7.13B | 8.9B |
| Year Ago Sales | 1.54B | 1.57B | 5.86B | 6.97B |
| Sales Growth (year/est) | 23.55% | 21.00% | 18.97% | 18.99% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ANET.MX | -- | -- | -- | -- |
| S&P 500 | 9.26% | 11.36% | 13.91% | 13.52% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 1/17/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 1/17/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 12/17/2024 |
| Maintains | Barclays: Overweight to Overweight | 12/4/2024 |
| Maintains | Rosenblatt: Sell to Sell | 11/8/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/8/2024 |